Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease
Aim. To assess the effect of rifaximin and a multi-strain probiotic on the intestinal microbiome and the indicators of cardiovascular risk in patients with coronary heart disease (CHD).Materials and methods. A study conducted during the 2016–2019 period included 120 people over 50 years old divided...
Saved in:
| Main Authors: | E. A. Kashukh, E. A. Poluektova, A. V. Kudryavtseva, G. S. Krasnov, V. I. Kazey, P. D. Sobolev, P. V. Gremyakova, V. T. Ivashkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2019-09-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations of first-trimester TMAO and its precursors with gestational diabetes mellitus: a pilot prospective cohort study
by: Geng-Dong Chen, et al.
Published: (2025-06-01) -
Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
by: S. I. Achkasov, et al.
Published: (2012-04-01) -
GUT ENTEROBIOTA — A NEW PLAYER IN ATHEROSCLEROSIS PATHOGENESIS
by: L. V. Egshatyan, et al.
Published: (2014-12-01) -
Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020-09-01) -
Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
by: Ylenia Heinrich-Sanchez, et al.
Published: (2025-12-01)